Innovative mono- or bi-conjugated ADCs targeting PARP3 in triple negative breast cancer

8 déc. 2022
13h30 15h
Salle JF LEFEVRE

Agathe BOOS (DANTZER team UMR7242) & Julien MOST (WAGNER team UMR7199)

Consulter l'agenda complet